Impact of initial dialysis modality on mortality: a propensity-matched study

Area of Science:

• Nephrology
• Renal Replacement Therapy
• Public Health

Background:

• The impact of dialysis modality on end-stage renal disease (ESRD) patient mortality remains unclear, with limited randomized controlled trial data.
• Observational studies using propensity-matched analyses can elucidate the independent effects of peritoneal dialysis (PD) versus hemodialysis (HD) on mortality.

Purpose of the Study:

• To compare all-cause and cardiovascular mortality between patients initiating PD and HD as their first renal replacement therapy.
• To assess the influence of patient demographics (age, gender, diabetes) on the relationship between dialysis modality and mortality.

Main Methods:

• A propensity-matched observational study of 692 pairs of patients initiating dialysis in Norway (2005-2012).
• As-treated and intention-to-treat analyses were performed to evaluate 2- and 5-year all-cause and cardiovascular mortality.
• Interaction analyses explored modality effects across age, gender, and diabetes strata.

Main Results:

• No significant difference in 2- or 5-year all-cause mortality between PD and HD overall.
• Patients under 65 initiating PD demonstrated significantly lower 2- and 5-year all-cause mortality compared to HD.
• Younger PD patients (<65 years) also showed reduced 5-year cardiovascular mortality; PD was not associated with worse outcomes in any subgroup.

Conclusions:

• Peritoneal dialysis (PD) is not inferior to hemodialysis (HD) in terms of survival for ESRD patients.
• PD offers superior survival benefits for patients under 65 years old.
• Increased utilization of PD as an initial dialysis modality for ESRD patients is recommended.